E-selectin inhibitor is superior to low-molecular-weight heparin for the treatment of experimental venous thrombosis.
J Vasc Surg Venous Lymphat Disord
; 10(1): 211-220, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-33872819
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glycolipids
/
Heparin, Low-Molecular-Weight
/
E-Selectin
/
Venous Thrombosis
/
Anticoagulants
Limits:
Animals
Language:
En
Journal:
J Vasc Surg Venous Lymphat Disord
Year:
2022
Document type:
Article
Country of publication:
United States